Róbert Király
CímIdézteÉv
In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies
IR Korponay-Szabó, T Halttunen, Z Szalai, K Laurila, R Kiraly, JB Kovacs, ...
Gut 53 (5), 641-648, 2004
3452004
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits
TT Salmi, P Collin, IR Korponay-Szabo, K Laurila, J Partanen, H Huhtala, ...
Gut 55 (12), 1746-1753, 2006
2342006
Coeliac disease case finding and diet monitoring by point‐of‐care testing
IR KORPONAY‐SZABÓ, T Raivio, K Laurila, J Opre, R Kiraly, JB Kovacs, ...
Alimentary pharmacology & therapeutics 22 (8), 729-737, 2005
832005
Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+‐dependent action of a multifunctional protein
R Király, MÁ Demény, L Fésüs
The FEBS journal 278 (24), 4717-4739, 2011
702011
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects
Z Simon-Vecsei, R Király, P Bagossi, B Tóth, I Dahlbom, S Caja, É Csősz, ...
Proceedings of the National Academy of Sciences 109 (2), 431-436, 2012
692012
Functional significance of five noncanonical Ca2+‐binding sites of human transglutaminase 2 characterized by site‐directed mutagenesis
R Király, É Csősz, T Kurtán, S Antus, K Szigeti, Z Simon‐Vecsei, ...
The FEBS journal 276 (23), 7083-7096, 2009
692009
Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize
IR Korponay-Szabó, Z Vecsei, R Király, I Dahlbom, F Chirdo, É Nemes, ...
Journal of pediatric gastroenterology and nutrition 46 (3), 253-261, 2008
672008
Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness
R Király, Z Vecsei, T Deményi, IR Korponay-Szabó, L Fésüs
Journal of autoimmunity 26 (4), 278-287, 2006
542006
Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity
K Kanchan, E Ergülen, R Király, Z Simon-Vecsei, M Fuxreiter, L Fésüs
Biochemical Journal 455 (3), 261-272, 2013
272013
Transglutaminase 2 dysfunctions in the development of autoimmune disorders: celiac disease and TG2-/-mouse
Z Szondy, I Korponay-Szabó, R Király, L Fésüs
Advances in enzymology and related areas of molecular biology 78, 295, 2011
182011
Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions
R Király, E Barta, L Fésüs
Amino Acids 44 (1), 215-225, 2013
132013
Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2
B Biri, B Kiss, R Király, G Schlosser, O Láng, L Kőhidai, L Fésüs, L Nyitray
Biochemical Journal 473 (1), 31-42, 2016
112016
Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters
R Király, K Thangaraju, Z Nagy, R Collighan, Z Nemes, M Griffin, L Fésüs
Amino acids 48 (1), 31-40, 2016
102016
Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate
K Thangaraju, B Biri, G Schlosser, B Kiss, L Nyitray, L Fésüs, R Király
Analytical biochemistry 505, 36-42, 2016
32016
Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function
K Thangaraju, R Király, JA Mótyán, VA Ambrus, M Fuxreiter, L Fésüs
Amino acids 49 (3), 605-614, 2017
22017
Diagnosis and treatment of gluten-induced autoimmune diseases
I Korponay-Szabó, L Fésüs, É Csösz, R Király, Z Simon-Vecsei, M Mäki, ...
US Patent App. 13/262,211, 2013
22013
A coeliakiás ellenanyagok epitóspecificitásának jelentősége a transzglutamináz autoantitestek diagnosztikus kimutatásában
J Tumpek, IR Korponay-Szabó, R Király, I Csípő, L Fésüs, S Sipka
Gyermekgyógyászat 55, 453-459, 2004
22004
Diagnosis of Gluten-Induced Autoimmune Diseases
I Korponay-Szabó, L Fésüs, P Bagossi, E Csósz, R Király, Z Simon-Vecsei, ...
US Patent App. 13/262,381, 2013
12013
Effect of coeliac autoantibodies on the enzymatic activity of tissue transglutaminase
R Kiraly, T Demenyi, I Korponay-Szabo, L Fesus
Minerva Biotecnologica 14 (2), 193, 2002
12002
A gluten-enteropathia kialakulását befolyásoló tényezők vizsgálata= Factors influencing the development of coeliac disease
IR Korponay-Szabó, B Barabás, É Csősz, R Király, A Miskeiné Kapitány, ...
OTKA Kutatási Jelentések| OTKA Research Reports, 2011
2011
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20